lysergic acid diethylamide has been researched along with Chronic Pain in 5 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
Chronic Pain: Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recently, there has been interest in lysergic acid diethylamide (LSD) and psilocybin for depression, anxiety and fear of death in terminal illness." | 8.98 | Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role? ( Johnson, MI; Whelan, A, 2018) |
| "We aim to provide an evidence-based overview of the use of psychedelics in chronic pain, specifically LSD and psilocybin." | 5.41 | Are psychedelics the answer to chronic pain: A review of current literature. ( Kooijman, NI; Kramers, C; Mulleners, WM; Reuser, A; van der Wal, SEI; Vissers, KCP; Willegers, T, 2023) |
| "The therapeutic potential of psychedelics in headache and chronic pain disorders is documented over decades of anecdotal and early investigational reports, which have paved the way for the first controlled studies of psilocybin and lysergic acid diethylamide (LSD) in these disorders." | 5.22 | Psychedelics in the Treatment of Headache and Chronic Pain Disorders. ( Schindler, EAD, 2022) |
| "Recently, there has been interest in lysergic acid diethylamide (LSD) and psilocybin for depression, anxiety and fear of death in terminal illness." | 4.98 | Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role? ( Johnson, MI; Whelan, A, 2018) |
| "Chronic pain is a leading cause of disability, reduced productivity, healthcare seeking behavior, and a contributor to opioid overdose in the United States." | 3.01 | Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs. ( Baumann, MH; Belouin, SJ; Berger, A; Dworkin, RH; Ghauri, MH; Hendricks, PS; Henningfield, JE; Lanier, RK; Ross, S; Zia, FZ, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schindler, EAD | 1 |
| Kooijman, NI | 1 |
| Willegers, T | 1 |
| Reuser, A | 1 |
| Mulleners, WM | 1 |
| Kramers, C | 1 |
| Vissers, KCP | 1 |
| van der Wal, SEI | 1 |
| Zia, FZ | 1 |
| Baumann, MH | 1 |
| Belouin, SJ | 1 |
| Dworkin, RH | 1 |
| Ghauri, MH | 1 |
| Hendricks, PS | 1 |
| Henningfield, JE | 1 |
| Lanier, RK | 1 |
| Ross, S | 1 |
| Berger, A | 1 |
| Das, S | 1 |
| Maiti, T | 1 |
| Whelan, A | 1 |
| Johnson, MI | 1 |
4 reviews available for lysergic acid diethylamide and Chronic Pain
| Article | Year |
|---|---|
Psychedelics in the Treatment of Headache and Chronic Pain Disorders.
Topics: Chronic Pain; Hallucinogens; Headache; Humans; Lysergic Acid Diethylamide; Psilocybin | 2022 |
Are psychedelics the answer to chronic pain: A review of current literature.
Topics: Chronic Pain; Cluster Headache; Hallucinogens; Humans; Lysergic Acid Diethylamide; Neoplasms; Psiloc | 2023 |
Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.
Topics: Chronic Pain; Depressive Disorder, Major; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocy | 2023 |
Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?
Topics: Anxiety; Chronic Pain; Depression; Humans; Lysergic Acid Diethylamide; Pain; Psilocybin; Serotonin R | 2018 |
1 other study available for lysergic acid diethylamide and Chronic Pain
| Article | Year |
|---|---|
Lysergic acid diethylamide as an analgesic agent in patients with terminal illnesses.
Topics: Analgesics; Chronic Pain; Humans; Lysergic Acid Diethylamide; Terminally Ill | 2020 |